Expert Interview
Discussing the potential of Rhythm Pharma's setmelanotide in treating Bardet-Biedl Syndrome
Ticker(s): RYTMInstitution: University Hospital Birmingham
- Consultant nephrologist at University Hospital Birmingham; Overseas the adult BBS clinic in the QEH in Birmingham and works closely with Birmingham Children’s Hospital who provide the paediatric counterpart for the service.
- Clinic treats 110 patients with Bardet-Biedl Syndrome.
- Research focuses on ADPKD and other renal genetic diseases including polycystic renal disease, Alport’s syndrome, uromodulin mediated disease and many other rare conditions.
Roughly how many patients do you currently manage with BBS?
Added By: c_adminWhat is the standard of care for this disorder?
Added By: c_adminOn a scale from 1-10 (10 being extremely excited) where would you rate your level of excitement for setmelanotide?
Added By: c_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
